Atea Pharmaceuticals, Inc. — Director's Dealing 2024

Jun 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Atea Pharmaceuticals, Inc. (AVIR)
CIK: 0001593899
Period of Report: 2024-06-16

Reporting Person: Lucidi Bruno (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-16	Common Stock	M	33150	$0.00	Acquired	83150	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-16	Restricted Stock Units	$	M	33150	Disposed		Common Stock (33150)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: The restricted stock units are fully vested.

F3: The restricted stock units do not have an expiration date.